C-Rad AB

Equities

CRAD B

SE0002016352

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Stockholm Other stock markets 12:00:00 2024-07-16 pm EDT			5-day change	1st Jan Change
44.2 ^SEK	-0.79%		+0.45%	+4.74%

Jun. 20	C-Rad AB Announces Chief Financial Officer Changes	CI
May. 14	Transcript : C-Rad AB, Q1 2024 Earnings Call, May 14, 2024

C-RAD Web Presentation Interim Report Q2 2024

July 08, 2024 at 07:45 am EDT

Invitation to join the presentation of C-RADs second quarter 2024.

Date: Tuesday June 18, 2024 / kl. 11:00 CET

Venue: Online Presentation

Topic: C-RAD Interim Report Q2 2024

Procedure:

Please register online through the website:

https://us06web.zoom.us/webinar/register/WN_vYb177xYQmuG9maH_YN6hw

After registration, you will receive a confirmation via email.

A recording of the presentation will be made accessible on the C-RAD website after the presentation.

About C-RAD

C-RAD develops surface-guided imaging solutions for radiation therapy to allow highly accurate dose delivery to the tumor, and at the same time, to protect healthy tissue from unwanted exposure. Using high-speed 3D cameras combined with augmented reality, C-RAD supports the initial patient setup process and monitors the patient's motion during treatment to ensure high confidence, an efficient workflow, and improved accuracy. C-RAD monitors the patient's motion without the use of tattoos or additional imaging dose, to deliver the highest level of patient safety and comfort.

C-RAD. Inspiring excellence in cancer treatment.

C-RAD AB is listed on NASDAQ Stockholm.

For more information on C-RAD, please visit http://www.c-rad.com

Latest news about C-Rad AB

C-Rad AB Announces Chief Financial Officer Changes	Jun. 20	CI
Transcript : C-Rad AB, Q1 2024 Earnings Call, May 14, 2024	May. 14
C-Rad AB Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 14	CI
C-Rad AB Appoints Jonas Reinhammar as Interim CFO	May. 13	CI
C-RAD Partners with RaySearch Laboratories to Improve Radiation Therapy	May. 06	MT
RaySearch Laboratories AB and C-RAD Sign Collaboration Agreement	May. 04	CI
C-Rad AB Appoints Mats Thorén as Board Member	Apr. 24	CI
C-RAD Announces Resignation of Christoffer Herou as CFO, Effective September 25, 2024	Mar. 25	CI
C-RAD Receives an Order of SEK 12 Million from Italy, Related to an Extension of the National Consip Tender	Mar. 21	CI
Transcript : C-Rad AB, Q4 2023 Earnings Call, Feb 08, 2024	Feb. 08
C-Rad AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 08	CI
C-Rad AB Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 08	CI
C-Rad AB Wins Order in Croatia of SEK 16 Million	Jan. 29	CI
C-RAD AB Announces Order from Accuray	Jan. 15	CI
C-RAD Expands its Presence in South Korea, Soon Supplying Multiple Centers with SGRT Systems	Nov. 28	CI
Transcript : C-Rad AB, Q3 2023 Earnings Call, Oct 27, 2023	23-10-27
C-Rad AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23-10-27	CI
C-RAD Signs Partnership Agreement with New Customer in Germany	23-10-26	CI
Katholisches Klinikum Bochum Ggmbh - St. Josef Hospital in Bochum, Germany Decides to Use the C-RAD SGRT Solution in Its Modernised Radiotherapy	23-09-15	CI
C-Rad AB (OM:CRAD B) commences an Equity Buyback Plan, under the authorization approved on May 5, 2023.	23-08-21	CI
C-RAD Announces Breast Cancer Treatment Option with Surface Guidance Now Available for Clinical Use in U.S	23-08-14	CI
Transcript : C-Rad AB, Q2 2023 Earnings Call, Jul 20, 2023	23-07-20
C-Rad AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-07-20	CI
C-Rad AB to Demonstrate Enhancements in Surface Guided Solutions for Advanced Radiotherapy Treatments at AAPM	23-07-18	CI
C-Rad AB Expands Its Collaboration with Mvz Prof. Dr. Uhlenbrock Und Partner	23-06-30	CI

Chart C-Rad AB

Duration

Period

More charts

Company Profile

C-Rad AB is a Sweden-based holding company active in the medical equipment industry. It offers products and solutions to the radiation therapy market. C-Rad AB is the parent company within the C-Rad group (the Group). The Group provides such products, as Sentinel, a surface contour laser scanning system for patient positioning, monitoring and gating applications; Catalyst, a surface scanning system, which allows the identification and tracking of markers, and GEMini, a system based on a gaseous detector using metal converters interleaved with Gas Electron Multipliers (GEMs), as well as other products. The Company operates through several subsidiaries: C-RAD Positioning AB, C-RAD Imaging AB, C-RAD Innovation AB and Cyrpa International Sprl. The Companyâs largest shareholder is Inter Life Science AB.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-07-18 - Q2 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for C-Rad AB

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

44.2 SEK

Average target price

55 SEK

Spread / Average Target

+24.43%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
C-RAD AB	+4.74%	142M
THERMO FISHER SCIENTIFIC	+4.64%	208B
DANAHER CORPORATION	+8.99%	182B
INTUITIVE SURGICAL, INC.	+29.83%	155B
BOSTON SCIENTIFIC CORPORATION	+35.17%	115B
SIEMENS HEALTHINEERS AG	+2.55%	66.52B
EDWARDS LIFESCIENCES CORPORATION	+15.06%	53.93B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-6.47%	46.26B
AGILENT TECHNOLOGIES, INC.	-2.14%	38.22B
GE HEALTHCARE TECHNOLOGIES INC.	+6.88%	36.6B

Other Advanced Medical Equipment & Technology